top of page
white new logo.png


One Test. One Pill. Save Two Lives.
Predicting and preventing preeclampsia
end to end solution.png
MirZyme is developing the ONLY end-to-end solution to prevent preeclampsia, so that lives LOST can become lives LIVED

Every minute a life is lost due to preeclampsia

preeclmapsia - the unsolved problem.png


MirZyme Therapeutics offers the end-to-end preeclampsia solution. It is an early-stage clinical women's health biopharmaceutical company that has uncovered what causes preeclampsia and how to predict and prevent it. We have a pipeline of tailored therapeutics to prevent preeclampsia and Small for Gestational Age babies. 


Our digital diagnostic algorithm takes blood test results and tells a pregnant woman half way through pregnancy if she is going to develop preeclampsia.


MirZyme has a highly skilled, diverse, and deeply dedicated team. The core team have worked together for over a decade.

vision image updated_edited.png
vision image updated_edited.jpg
mission vision update_edited.png
Who are we

Notable Achievements

$40M non-dilutive competitive grants awarded leading to breakthrough innovation
Global patents granted in 30 countries
Novel diagnostic algorithm proven in human clinical trials
Fast-track Innovation Passport awarded by Medicines & Healthcare products Regulatory Agency for development of MirZyme's primary medicine
Recognized by Department for Science, Innovation & Technology as a UK leading FemTech in Biotechology
How it works

Our Science

MirZyme has successfully completed preclinical efficacy studies in widely used disease models and has conducted effective, prospective clinical diagnostic studies in humans using the company’s proprietary know-how and intellectual property.

Our pipeline of products 

concept logo_edited.png

Supported By....

Get in touch

To get in touch with the team please fill out the form below

Thank you for your message!


MirZyme Therapeutics, Birmingham, B7 4BB, UK

bottom of page